28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction

Key Takeaways Explain This Topic AI

Sudden Sensorineural Hearing Loss (SSNHL) is a critical otologic emergency defined by ≥30 dB hearing loss across at least 3 contiguous audiometric frequencies developing over ≤72 hours, frequently masquerading as benign Eustachian tube dysfunction or cerumen impaction.

Bedside 512 Hz tuning fork testing readily unmasks sensorineural loss: the Weber test lateralizes to the UNAFFECTED (normal) ear, and the Rinne test demonstrates air conduction greater than bone conduction bilaterally (positive Rinne), directly contrasting with conductive loss where Weber lateralizes to the affected ear and Rinne is negative (BC > AC).

High-dose systemic oral corticosteroids (prednisone 1 mg/kg/day, maximum 60 mg daily for 10-14 days followed by a taper) must be instituted immediately within the critical 2-to-4-week golden window to rescue cochlear hair cells and maximize hearing recovery.

Pulsatile tinnitus synchronizes with the patient's heartbeat and represents an urgent neurovascular red flag requiring prompt cross-sectional imaging (CTA or MRA of the head and neck) to evaluate for dural arteriovenous fistulas, carotid stenosis, glomus tumors, or idiopathic intracranial hypertension.

Ear canal irrigation for cerumen impaction must strictly utilize body-temperature water (37°C / 98.6°F) to avoid triggering the caloric reflex (which induces violent horizontal nystagmus, severe vertigo, and emesis), and is absolutely contraindicated in patients with tympanic membrane perforation or prior otologic surgery.

Last updated: September 2026

Sudden Sensorineural Hearing Loss (SSNHL): Emergency Triage & Management

Sudden Sensorineural Hearing Loss (SSNHL) is an alarming otologic emergency defined by the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) as a sensorineural hearing deficit of ≥30 decibels (dB) across at least 3 contiguous audiometric frequencies developing over a period of ≤72 hours . It has an annual incidence of 5 to 20 per 100,000 individuals, occurring predominantly in adults aged 40 to 60 years.

Etiology & Pathophysiology

In over 85% to 90% of cases, no clear systemic cause is initially identified, classifying the condition as Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) . The three prevailing pathophysiological mechanisms include:

Microvascular Ischemia : The cochlea is an end-organ vascular territory supplied exclusively by the labyrinthine artery (internal auditory artery), which typically arises from the anterior inferior cerebellar artery (AICA) or directly from the basilar artery. Because the labyrinthine artery lacks collateral anastomosis, transient thromboembolism, microvascular vasospasm, or hyperviscosity produces immediate, irreversible ischemic injury to the high-metabolic stria vascularis and organ of Corti.

Viral Cochleitis / Labyrinthitis : Reactivation of latent herpesviridae (HSV-1, VZV, CMV) or systemic infection (mumps, rubella, enterovirus) causes inflammatory destruction of hair cells and auditory nerve fibers.

Autoimmune Inner Ear Disease (AIED) : Local antibody deposition and complement activation targeting inner ear antigens (e.g., cochlin, heat shock protein 70).

Identifiable Secondary Causes : Vestibular schwannoma (acoustic neuroma, accounting for 3% to 10% of presentations), anterior inferior cerebellar artery (AICA) posterior circulation ischemic stroke, Lyme disease, syphilis ( Treponema pallidum ), multiple sclerosis, trauma, or perilymphatic fistula.

The Clinical Presentation & The 'Clogged Ear' Pitfall

Patients typically report discovering profound hearing impairment upon awakening ('waking up deaf in one ear'), or noticing sudden muffled hearing while holding a telephone to the affected ear. Crucially, over 80% of patients report a sensation of unilateral ear fullness, pressure, or feeling 'clogged' , frequently accompanied by acute subjective tinnitus and mild vertigo (30-40%).

The Dangerous Diagnostic Pitfall : In primary care and urgent care settings, clinicians frequently attribute unilateral ear fullness to cerumen impaction, acute otitis media with effusion, or Eustachian tube dysfunction. Patients are inappropriately discharged with oral antihistamines, decongestants, or antibiotics. This diagnostic delay causes patients to miss the critical golden therapeutic window (≤2 to 4 weeks) during which corticosteroids can rescue apoptotic cochlear hair cells. Any adult presenting with acute unilateral muffled hearing or aural fullness with a normal tympanic membrane must be presumed to have SSNHL until proven otherwise!

Bedside Tuning Fork Clinical Differentiation (512 Hz)

When formal audiometry is not immediately accessible, a 512 Hz tuning fork provides indispensable bedside differentiation between sensorineural and conductive hearing loss. (Higher frequencies such as 1024 Hz decay too rapidly, while lower frequencies such as 128 Hz or 256 Hz produce vibrotactile somatosensory artifacts): 512 Hz BED-SIDE TUNING FORK EXAMINATION

• WEBER TEST (Midline Forehead)
• │
• ┌──────────────────────┴──────────────────────┐
• ▼ ▼
• Sound Lateralizes to Sound Lateralizes to
• UNAFFECTED (Healthy) Ear AFFECTED (Impaired) Ear
• │ │
• ▼ ▼
• SENSORINEURAL HEARING LOSS CONDUCTIVE HEARING LOSS
• (Damaged Cochlea Cannot Sense) (Occlusion Amplifies Bone Resonance)

───

• RINNE TEST (Air vs. Bone Conduction)
• │
• ┌──────────────────────┴──────────────────────┐
• ▼ ▼
• Air Conduction > Bone Conduction Bone Conduction > Air Conduction
• [Positive Rinne] (AC > BC) [Negative Rinne] (BC > AC)
• │ │
• ▼ ▼
• NORMAL or SENSORINEURAL LOSS CONDUCTIVE HEARING IMPAIRMENT
• (Conductive Mechanism Intact) (Sound Wave Blocked in Canal/Middle)
• Diagnostic Tuning Fork Matrix

Clinical Condition Weber Test Lateralization Rinne Test: Affected Ear Rinne Test: Normal Ear Clinical Interpretation

Normal Auditory Function Midline (equally loud both sides) AC > BC (Positive) AC > BC (Positive) Normal acoustic mechanics

Sudden Sensorineural Hearing Loss (Right Ear) Lateralizes to LEFT (Normal ear) AC > BC (Positive) AC > BC (Positive) Right cochlea/CN VIII impaired; conducts air better than bone, but signal reduced

Conductive Hearing Loss (e.g., Cerumen / Effusion Right Ear) Lateralizes to RIGHT (Affected ear) BC > AC (Negative) AC > BC (Positive) Ambient background noise blocked; bone vibration amplified in right ear

Emergency Management & Treatment Guidelines SSNHL EMERGENCY CLINICAL PROTOCOL

• Acute Unilateral Subjective Hearing Loss Peaking <=72 Hours
• │
• ▼
• Bedside 512 Hz Tuning Forks + Urgent Audiogram
• (Confirm Sensorineural Loss >=30 dB across 3 Freq)
• │
• ▼
• START IMMEDIATE HIGH-DOSE SYSTEMIC CORTICOSTEROIDS
• Oral Prednisone 1 mg/kg/day (Max 60 mg daily) x 10-14 days
• Followed by 7-10 day taper (Total course: ~3 weeks)
• │
• ┌────────────────────┴────────────────────┐
• ▼ ▼
• Systemic Steroids Contraindicated Refractory Loss at 2-3 Weeks
• (Brittle Diabetes, Severe Psych, Ulcer) (Incomplete Audiometric Recovery)
• │ │
• └────────────────────┬────────────────────┘
• ▼
• INTRATYMPANIC CORTICOSTEROID INJECTIONS
• Dexamethasone 10-24 mg/mL or Methylprednisolone
• High local perilymph drug concentrations
• │
• ▼
• MANDATORY NEUROIMAGING (ALL PATIENTS)
• Contrast-Enhanced Brain MRI (IAC Protocol)
• Rule out Vestibular Schwannoma (~3-10%) & AICA Stroke
• 1. Systemic High-Dose Corticosteroids

The Cornerstone of Therapy : According to the AAO-HNS Clinical Practice Guidelines, systemic corticosteroids represent the primary evidence-based intervention for SSNHL.

Regimen : Oral Prednisone 1 mg/kg/day as a single morning dose (maximum 60 mg daily) for 10 to 14 days , followed by a 7- to 10-day gradual taper (total treatment 21 days). Alternative: Methylprednisolone (Medrol) 48 mg daily for 10-14 days then taper.

The Golden Therapeutic Window : Corticosteroids must be instituted as early as possible, ideally within 72 hours and strictly within 2 to 4 weeks from symptom onset. Beyond 4 weeks, hair cell loss and fibrocellular reorganization in the cochlea are permanent, and steroids show zero efficacy over placebo.

2. Intratympanic (IT) Corticosteroid Injections

Trans-tympanic administration of high-concentration dexamethasone (10-24 mg/mL) or methylprednisolone into the middle ear space, where it diffuses across the round window membrane directly into the scala tympani and perilymph.

Indications :

Salvage / Rescue Therapy : For patients with incomplete audiometric recovery 2 to 3 weeks following completion of initial oral systemic steroids.

Primary Therapy : In patients with absolute or relative contraindications to high-dose systemic steroids, such as brittle diabetes mellitus (avoiding hyperglycemic hyperosmolar non-ketotic crises), active peptic ulcer disease, or severe psychiatric disorders (steroid psychosis).

3. Mandatory Diagnostic Neuroimaging

Contrast-Enhanced Brain MRI with Internal Auditory Canal (IAC) Protocol (thin-slice T1 post-gadolinium and CISS/FIESTA sequences) is mandatory in 100% of patients with confirmed SSNHL , even if hearing fully recovers with steroids!

Vestibular Schwannoma (Acoustic Neuroma) : Accounts for 3% to 10% of all cases of presumed idiopathic SSNHL. A small intracanalicular schwannoma compressing the cochlear nerve within the internal auditory meatus commonly presents with sudden, rather than insidious, hearing loss.

If MRI is contraindicated (e.g., non-MRI-compatible metallic implants), Auditory Brainstem Response (ABR) testing or high-resolution temporal bone CT is indicated.

Acute Tinnitus: Subjective vs. Pulsatile / Objective Differentiation

Tinnitus is the perception of sound in the absence of an external acoustic stimulus. In family medicine, the single most crucial clinical distinction is separating benign subjective non-pulsatile tinnitus from high-risk objective or pulsatile tinnitus . TINNITUS CLINICAL TAXONOMY

• SUBJECTIVE TINNITUS (>99% of Cases) PULSATILE / OBJECTIVE (<1% of Cases)
• ──────────────────────────────────────────────────────────────────────────
• Audible ONLY to the patient • Audible to examiner or pulse-synchronous
• Continuous ringing, buzzing, hissing • Rhythmic whooshing, thumping, clicking
• Mechanism: Cochlear deafferentation • Mechanism: True mechanical vascular flow
• causing maladaptive cortical firing or neuromuscular contractions
• Etiologies: Presbycusis, acoustic • Etiologies: dAVF, AVM, Carotid stenosis,
• trauma, ototoxic medications, SSNHL Glomus tumors, Intracranial hypertension
• Workup: Audiometry, drug review • Workup: MANDATORY CTA / MRA Head & Neck
• Subjective Tinnitus & Ototoxic Medications

Subjective tinnitus arises when damage to peripheral auditory receptors (cochlear outer hair cells) reduces normal afferent neural output. This cochlear deafferentation triggers maladaptive neuroplastic disinhibition and unmasked spontaneous hyperactivity within the dorsal cochlear nucleus and primary auditory cortex.

High-Yield Ototoxic Pharmacological Agents

Drug Class Specific Agents Mechanism of Cochlear / Vestibular Damage Clinical Features & Reversibility

Aminoglycosides Gentamicin, Tobramycin, Amikacin, Streptomycin Generate reactive oxygen species (ROS) in inner ear; trigger apoptosis of hair cells High-frequency sensorineural hearing loss + severe vestibular toxicity; IRREVERSIBLE

Platinum Chemotherapy Cisplatin, Carboplatin Accumulates in stria vascularis; damages outer hair cells in basal cochlear turn Bilateral irreversible high-frequency loss, prominent tinnitus; dose-dependent

Loop Diuretics Furosemide, Bumetanide, Torsemide Inhibit Na-K-2Cl cotransporters in stria vascularis, disrupting endolymph endocochlear potential Hearing loss and roaring tinnitus; typically reversible upon drug cessation (unless combined with aminoglycosides)

Salicylates / NSAIDs High-dose Aspirin (>2-4 g/day), Indomethacin Reversibly inhibits prestin motor protein in outer hair cells; alters cochlear blood flow Moderate-to-high pitched bilateral tinnitus; fully reversible within 48-72h of stopping

Phosphodiesterase-5 Inhibitors Sildenafil, Tadalafil Alters cyclic GMP signaling in cochlear vasculature Rare acute sudden sensorineural hearing loss; mandates immediate drug discontinuation

Pulsatile Tinnitus: Master Differential & Neurovascular Workup

Pulsatile tinnitus describes an auditory perception that rhythmically synchronizes with the patient's arterial pulse (whooshing, thumping, or pumping sound). It indicates turbulent blood flow through intracranial or cervical vessels, transmitting sound across the petrous temporal bone to the inner ear:

Dural Arteriovenous Fistula (dAVF) or Malformation (AVM) : Abnormal high-flow shunt between meningeal arteries and dural venous sinuses (e.g., transverse or sigmoid sinus). High risk of catastrophic intracranial hemorrhage!

Internal Carotid Artery Stenosis or Dissection : Atherosclerotic narrowing or intimal flap generating turbulent flow; auscultation over the neck or mastoid may reveal a vascular bruit.

Paraganglioma (Glomus Tympanicum or Glomus Jugulare Tumor) : Highly vascularized neuroendocrine tumors arising along Jacobson's nerve (CN IX) or Arnold's nerve (CN X). Otoscopic examination classically reveals a pulsatile, reddish-blue, vascular retrotympanic mass behind an intact tympanic membrane.

Idiopathic Intracranial Hypertension (IIH / Pseudotumor Cerebri) : Elevated intracranial pressure transmitted to the dural venous sinuses, causing secondary stenosis of the transverse sinus. Most common in obese women of childbearing age; presents with pulsatile tinnitus, severe headache, transient visual obscurations, and papilledema on funduscopic examination.

Mandatory Diagnostic Workup for Pulsatile Tinnitus : Every patient with pulsatile tinnitus requires urgent cross-sectional neurovascular imaging: CT Angiography (CTA) or Magnetic Resonance Angiography and Venography (MRA/MRV) of the head and neck . Normal otoscopy does NOT rule out life-threatening intracranial vascular pathology.

Cerumen Impaction: Safe Removal & The Caloric Reflex

Cerumen (earwax) is a normal physiological substance composed of secretions from sebaceous and modified apocrine (ceruminous) glands combined with desquamated squames. It provides protective lubrication, traps foreign matter, and possesses antimicrobial properties due to an acidic pH (~6.0) and lysozyme content.

Indications for Intervention

Cerumen removal is indicated only when it is symptomatic (producing conductive hearing loss, ear fullness, otalgia, pruritus, tinnitus, reflex cough via Arnold's nerve, or vertigo) or when it occludes visualization of the tympanic membrane during diagnostic assessment. Routine prophylactic cleaning of asymptomatic non-occlusive cerumen is unnecessary and harmful.

Safe Removal Techniques & Protocols CERUMEN REMOVAL MODALITIES

• 1. CERUMENOLYTICS 2. IRRIGATION 3. MANUAL REMOVAL
• ┌─────────────────────┐ ┌─────────────────────┐ ┌─────────────────────┐
• │ Water- or Oil-based │ │ Syringe / Ear Wash │ │ Curettes, Forceps, │
• │ drops for 15-30 min │──▶│ with Body-Temp │ OR │ Gentle Suction │
• │ to soften the plug │ │ Water (37°C / 98.6°F│ │ Under Direct Vision │
• └─────────────────────┘ └─────────────────────┘ └─────────────────────┘
• │ ▲
• ▼ │
• CONTRAINDICATIONS PRESENT: │
• Tympanic Membrane Perforation │
• Patent Tympanostomy Tubes ──────────┘
• History of Ear Surgery
• 1. Cerumenolytic Pre-treatment

Instillation of cerumenolytic drops 15 to 30 minutes prior to irrigation significantly softens hard impactions, reducing the irrigation volume and mechanical pressure required:

Water-Based / Effervescent : Carbamide peroxide 6.5% otic drops, 3% hydrogen peroxide, or docusate sodium liquid. Hydrogen peroxide releases oxygen bubbles, mechanically fragmenting the cerumen plug.

Oil-Based : Mineral oil, liquid petrolatum, or olive oil (lubricates and softens dry keratic plugs).

2. Water Irrigation Technique & The Caloric Reflex

Irrigation Mechanics : Gentle stream of water directed toward the superior or posterior-superior external auditory canal wall , allowing water to flow behind the cerumen plug and flush it outward. Never aim the syringe directly at the center of the tympanic membrane!

Strict Temperature Requirement : Water MUST be warmed precisely to BODY TEMPERATURE (37°C / 98.6°F) .

The Caloric Reflex (Physiological Mechanism) : Non-isothermic water introduces a temperature gradient across the bony horizontal semicircular canal:

Cold Water Irrigation (<37°C) : Cools the endolymph in the horizontal semicircular canal, causing it to increase in density and sink (downward convection currents). This deflects the cupula away from the utricle (ampullofugal deflection), hyperpolarizing hair cells and triggering violent horizontal nystagmus with the fast phase beating to the OPPOSITE ear .

Warm Water Irrigation (>37°C) : Warms endolymph, causing it to expand and rise (ampullopetal deflection), generating nystagmus beating to the SAME ear ( COWS mnemonic: Cold Opposite, Warm Same ).

Clinical Consequence : Irrigating an ear with cold or hot water triggers acute uninhibited vestibular asymmetry, precipitating immediate severe rotational vertigo, intense diaphoresis, nausea, and intractable vomiting !

Absolute Contraindications to Ear Irrigation

Irrigating an ear in the presence of an unrecognized breach in the tympanic membrane introduces non-sterile water and cerumen debris under pressure directly into the middle ear, causing severe suppurative otitis media, ossicular disruption, perilymphatic fistula, or profound sensorineural hearing loss:

• Tympanic Membrane Perforation (known or suspected, including prior dry central perforations);
• History of Otologic Surgery (tympanoplasty, mastoidectomy, stapedectomy, ossiculoplasty);
• Presence of Patent Tympanostomy Tubes (grommets);

Active Acute Otitis Externa with canal wall erythema, severe edema, or pain on tragal traction (irrigation causes excruciating pain and spreads infection);

Foreign Bodies Composed of Vegetable Matter (e.g., beans, peas, seeds; water causes them to swell, exacerbating canal obstruction).

Management in Contraindicated Patients : Manual removal under direct visualization using an ear curette, right-angle hook, or gentle micro-suction is the mandatory method of choice.

Loading diagram... Clinical Algorithm for Acute Hearing Loss & Tinnitus Triage